Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 3707374
Author(s) Pröpster, Johannes M.; Yang, Fan; Rabbani, Said; Ernst, Beat; Allain, Frédéric H.-T.; Schubert, Mario
Author(s) at UniBasel Yang, Fan
Rabbani, Said
Ernst, Beat
Year 2016
Title Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8
Journal Proceedings of the National Academy of Sciences of the United States of America
Volume 113
Number 29
Pages / Article-Number E4170-9
Abstract Siglec-8 is a human immune-inhibitory receptor that, when engaged by specific self-glycans, triggers eosinophil apoptosis and inhibits mast cell degranulation, providing an endogenous mechanism to down-regulate immune responses of these central inflammatory effector cells. Here we used solution NMR spectroscopy to dissect the fine specificity of Siglec-8 toward different sialylated and sulfated carbohydrate ligands and determined the structure of the Siglec-8 lectin domain in complex with its prime glycan target 6'-sulfo sialyl Lewis(x) A canonical motif for sialic acid recognition, extended by a secondary motif formed by unique loop regions, recognizing 6-O-sulfated galactose dictates tight specificity distinct from other Siglec family members and any other endogenous glycan recognition receptors. Structure-guided mutagenesis revealed key contacts of both interfaces to be equally essential for binding. Our work provides critical structural and mechanistic insights into how Siglec-8 selectively recognizes its glycan target, rationalizes the functional impact of site-specific glycan sulfation in modulating this lectin-glycan interaction, and will enable the rational design of Siglec-8-targeted agonists to treat eosinophil- and mast cell-related allergic and inflammatory diseases, such as asthma.
Publisher National Academy of Sciences
ISSN/ISBN 0027-8424 ; 1091-6490
edoc-URL http://edoc.unibas.ch/52926/
Full Text on edoc No
Digital Object Identifier DOI 10.1073/pnas.1602214113
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/27357658
ISI-Number WOS:000380224500010
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.542 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024